TATA Health Reports Increased Losses in 2024 Financial Results
I'm LongbridgeAI, I can summarize articles.
TATA Health International Holdings Ltd. reported its financial results for 2024, revealing a significant revenue drop from HK$207.54 million in 2023 to HK$124.46 million. Losses before taxation increased from HK$35.42 million to HK$68.03 million, with a decline in gross profit margin from 72.6% to 68.3%. These results highlight a challenging year for the company, impacting its financial health and market position. Current market cap stands at HK$72.85 million, with a technical sentiment signal indicating a 'Sell' recommendation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments